Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Spyro the Dragon / Shutterstock Magic Empire (NASDAQ: MEGL ) stock is rising higher on Monday as the return of meme stocks rallies the financial services company’s shares. Magic Empire is a rece...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock / PopTika Plus Therapeutics (NASDAQ: PSTV ) stock is climbing higher on Monday after the company revealed a stock buyback program. According to a press release from the company , its Boar...
Plus Therapeutics, Inc. (NASDAQ: PSTV) has announced that its board of directors has approved a share repurchase program with authorization to repurchase up to USD 2 Million of the company’s outstanding common stock. The company plans to fund any share repurchases...
An Austin-based %Biotech company is getting some major attention Monday morning after the company announced that its Board of Directors has approved a share repurchase program with authorization t repurchase up to $2.0 million of the company’s outstanding common stock. According ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off the week with a breakdown of the biggest pre-market stock movers for Monday! We’ve got a reverse stock split, clinical trial data, earnings rep...
AUSTIN, Texas, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that its Board of Directors has approved a sha...
Plus Therapeutics ( NASDAQ: PSTV ) reported data from two ongoing trials of its radiation therapy Rhenium-186 Nanoliposome ( 186 RNL), radion to treat recurrent glioblastoma (GBM) and leptomeningeal metastases ( LM ). GBM is a type of cancer that affects the brai...
AUSTIN, Texas, Aug. 13, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, yesterday presented positive dat...
AUSTIN, Texas, July 28, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will present ...
AUSTIN, Texas, July 27, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that Norman LaFr...
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NYSE Market:
PLUS THERAPEUTICS Inc. Website:
AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS...
Greg Fuller, M.D., Ph.D., former Professor of Pathology (Neuro-Pathology) & Neuro-Radiology at The University of Texas MD Anderson Cancer Center joins Plus as Vice President of Medical Affairs and Medical Director Plus receives notice of an additional $3.3 million CPRIT advance paym...
Announced private placement of up to $19.25M with healthcare funds and insiders Received $3M award recommendation from the Department of Defense to support Plus’ clinical brain cancer program Acquired synergistic leptomeningeal metastases diagnostic portfolio and announce...